Suppr超能文献

《跨性别和性别多样化个体的医疗保健:ACOG 委员会意见,第 823 号》。

Health Care for Transgender and Gender Diverse Individuals: ACOG Committee Opinion, Number 823.

出版信息

Obstet Gynecol. 2021 Mar 1;137(3):e75-e88. doi: 10.1097/AOG.0000000000004294.

Abstract

An estimated 150,000 youth and 1.4 million adults living in the United States identify as transgender. This Committee Opinion offers guidance on providing inclusive and affirming care as well as clinical information on hormone therapy and preventive care; it also cites existing resources for those seeking information on the care of transgender adolescents. The social and economic marginalization of transgender individuals is widespread, which leads to health care inequities and poorer health outcomes for this population. To reduce the inequities experienced by the transgender community, the provision of inclusive health care is essential. Obstetrician-gynecologists should strive to make their offices open to and inclusive for all individuals and should seek out education to address health care disparities, both in their individual practices and in the larger health care system. In order to provide the best care for patients, it is useful to know which health care professionals to include in a referral network for primary care and to have many clinician and surgeon options given the many different therapies available and the different sites at which these therapies are offered. It is important to remember that although hormone therapy is a medically necessary treatment for many transgender individuals with gender dysphoria, not all transgender patients experience gender dysphoria and not everyone desires hormone treatment. Gender-affirming hormone therapy is not effective contraception. Sexually active individuals with retained gonads who do not wish to become pregnant or cause pregnancy in others should be counseled about the possibility of pregnancy if they are having sexual activity that involves sperm and oocytes. Although being knowledgeable about the medications used for gender transition and potential risks and side effects is important, specific certification for prescribing them is not required and should not be a limiting factor in helping patients access care.

摘要

据估计,美国有 15 万名青年人和 140 万成年人认同自己为跨性别者。本委员会意见提供了关于提供包容和肯定护理的指导,以及关于激素治疗和预防保健的临床信息;它还引用了那些寻求有关跨性别青少年护理信息的现有资源。跨性别者在社会和经济上普遍受到边缘化,这导致了该人群的医疗保健不平等和较差的健康结果。为了减少跨性别社区所经历的不平等,提供包容的医疗保健至关重要。妇产科医生应努力使他们的办公室对所有个人开放并包容,并寻求教育以解决医疗保健方面的差异,无论是在他们的个人实践中还是在更大的医疗保健系统中。为了为患者提供最佳护理,了解在初级保健中应包括哪些医疗保健专业人员以建立转介网络是有用的,并且鉴于有许多不同的治疗方法和提供这些治疗的不同地点,有许多临床医生和外科医生的选择也很重要。重要的是要记住,尽管激素治疗对于许多患有性别焦虑症的跨性别者来说是一种医学上必需的治疗方法,但并非所有跨性别患者都经历性别焦虑症,也不是每个人都希望接受激素治疗。性别肯定激素治疗不是有效的避孕措施。保留性腺且不想怀孕或不想使他人怀孕的有性行为的个体,如果他们进行涉及精子和卵子的性行为,应就怀孕的可能性进行咨询。虽然了解用于性别转换的药物以及潜在的风险和副作用很重要,但开处方的具体认证并非必需,也不应成为帮助患者获得护理的限制因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验